Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.23.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 6,806 $ 33,469
Restricted cash and cash equivalents—current 4,313 4,978
Accounts receivable, net 790 2,188
Inventory 1,477 1,535
Prepaid expenses and other current assets 11,818 22,615
Total current assets 25,204 64,785
Restricted cash and cash equivalents—non current 625 598
Vehicle deposits 43,979 48,783
Vehicles, net 85,693 100,088
Goodwill 30,083 0
Other assets 9,429 11,402
Total assets 195,013 225,656
Current liabilities:    
Accounts payable 21,469 20,235
Accrued expenses 28,520 33,413
Deferred revenue 43,161 47,820
Notes payable—current 21,014 22,200
Other current liabilities 8,330 10,950
Total current liabilities 122,494 134,618
Notes payable—non current (including $58.9 million at June 30, 2023 and $30.1 million at December 31, 2022 of Convertible Senior Secured Notes measured at fair value) 75,988 56,205
Derivative liabilities 840 1,892
Other liabilities 6,616 7,831
Total liabilities 205,938 200,546
Commitments and contingencies (Note 12)
Stockholders’ (Deficit) Equity    
Class A common stock, $0.0001 par value, 40,000,000 shares authorized, and 11,412,129 and 10,507,830 shares issued and outstanding as of June 30, 2023 and December 31, 2022, respectively, and Class X common stock, $0.0001 par value, 2,000,000 shares authorized, 1,381,398 shares issued and outstanding as of June 30, 2023 and December 31, 2022 32 30
Additional paid-in capital 1,589,717 1,572,576
Accumulated other comprehensive loss (7,171) (7,621)
Accumulated deficit (1,593,503) (1,539,875)
Total stockholders’ (deficit) equity (10,925) 25,110
Total liabilities and stockholders’ equity $ 195,013 $ 225,656